Olcegepant (INN,[1] code name BIBN-4096BS) is a calcitonin gene-related peptide receptor antagonist being studied as a potential treatment for migraines.

[2] A 2013 meta-analysis found olcegepant and telcagepant were effective and safe compared to placebo.

[3]

This drug article relating to the nervous system is a stub.

You can help Wikipedia by expanding it.